Transitional cell carcinoma of the endometrium and endometrial carcinoma with transitional cell differentiation

Cancer

Volumn 79, Issue 10, 1997, Pages 1933-1943

  Lininger, Ruth A ^a   Ashfaq, Raheela ^b   Albores Saavedra, Jorge ^b   Tavassoli, Fattaneh A ^a  

^a ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^b UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

bladder; cytokeratins 7 and 20; endometrium; ovary; transitional cell carcinoma

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN;

ABDOMINAL HYSTERECTOMY; ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL FEATURE; ENDOMETRIUM BIOPSY; ENDOMETRIUM CARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; PRIORITY JOURNAL; PROGNOSIS; SALPINGOOOPHORECTOMY; TRANSITIONAL CELL CARCINOMA; TREATMENT OUTCOME; UTERUS BLEEDING;

ADULT; AGED; AGED, 80 AND OVER; BLOOD VESSELS; CARCINOMA, TRANSITIONAL CELL; CELL DIFFERENTIATION; CHEMOTHERAPY, ADJUVANT; DIAGNOSIS, DIFFERENTIAL; ENDOMETRIAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYSTERECTOMY; KERATINS; MIDDLE AGED; MYOMETRIUM; NEOPLASM INVASIVENESS; OVARIAN NEOPLASMS; OVARIECTOMY; RADIOTHERAPY, ADJUVANT; SURVIVAL RATE; UTERINE HEMORRHAGE;

EID: 0030969119     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19970515)79:10<1933::AID-CNCR14>3.0.CO;2-W     Document Type: Article

References (49)

1. Austin RM, Norris HJ. Malignant Brenner tumor and transitional cell carcinoma of the ovary: a comparison. Int J Gynecol Pathol 1987; 6:29-39.
2. Hallgrimsson J, Scully R. Borderline and malignant Brenner tumours of the ovary: a report of 15 cases. Acta Pathol Microbiol Scand 1972; 80(Suppl 233):56-66.
3. Roth L, Czernobilsky B. Ovarian Brenner tumors II. Malignant. Cancer 1985; 56:592-601.
4. Roth L, Gersell D, Ulbright T. Ovarian Brenner tumors and transitional cell carcinoma: recent developments. Int J Gynecol Pathol 1993; 12:128-33.
5. Scully R. Tumors of the ovary and maldeveloped gonads. Atlas of tumor pathology. 2nd series. Fascicle 16. edition. Washington, DC: Armed Forces Institute of Pathology, 1979.
6. Shay M, Janovsky N. Malignant Brenner tumor associated with endometrial adenocarcinoma. Obstet Gynecol 1963; 22:246-52.
7. Svenes K, Eide J. Proliferative Brenner tumor or ovarian metastases? a case report. Cancer 1984; 53:2692-7.
8. van der Weiden R, Gratama S. Proliferative and malignant Brenner tumours (BT) and their differentiation from metastatic transitional cell carcinoma of the bladder: a case report and review of the literature. Eur J Obstet Gynecol Reprod Biol 1987; 26:251-60.
9. Woodruff J, Dietrich D, Genadry R, Parmley T. Proliferative and malignant Brenner tumors: review of 47 cases. Am J Obstet Gynecol 1981; 141:118-25.
10. Robey SS, Silva EG, Gershenson DM, McLemore D, El-Naggar A, Ordonez NG. Transitional cell carcinoma in high-grade high-stage ovarian carcinoma: an indicator of favorable response to chemotherapy. Cancer 1989; 63:839-47.
11. Silva EG, Robey-Cafferty SS, Smith TL, Gershenson DM. Ovarian carcinomas with transitional cell carcinoma pattern. Am J Clin Pathol 1990; 93:457-65.
12. Gershenson D, Silva E, Mitchell M, Atkinson E, Wharton J. Transitional cell carcinoma of the ovary: a matched control study of advanced-stage patients treated with cisplatin-based chemotherapy. Am J Obstet Gynecol 1993; 168:1178-87.
13. Sweeten K, Gershenson D, Burke T, Morris M, Levenback C, Silva E. Salvage chemotherapy for refractory transitional cell carcinoma of the ovary (TCC). Gynecol Oncol 1995; 59:211-5.
14. Albores-Saavedra J, Young R. Transitional cell neoplasms (carcinomas and inverted papillomas) of the uterine cervix: a report of five cases. Am J Surg Pathol 1995; 19:1138-45.
15. Sulaiman R, Manivel J. Papillary transitional cell carcinoma (TCC) of the uterine cervix and its histologic mimics. Mod Pathol 1996; 9:98A.
16. Koenig C, Turnicky RP, Kankam CF, Tavassoli FT. Papillary squamotransitional cell carcinoma of the cervix: a report of 32 cases. Am J Surg Pathol. In press.
17. Uehira K, Hashimoto H, Tsuneyoshi M, Enjoji M. Transitional cell carcinoma pattern in primary carcinoma of the fallopian tube. Cancer 1993; 72:2447-56.
18. Hovadhanakul P, Nuerenberger S, Ritter P, Taylor H, Cavanagh D. Primary transitional cell carcinoma of the fallopian tube associated with primary carcinomas of the ovary and endometrium. Gynecol Oncol 1976; 4:138-43.
19. Federman Q, Toker C. Primary transitional cell tumor of the uterine adnexa. Am J Obstet Gynecol 1973; 115:863-4.
20. Thomason R, Rush W, Dave H. Brief communication: transitional cell carcinoma arising within a paratubal cyst - report of a case. Int J Gynecol Pathol 1995; 14:270-3.
21. Spiegel G, Austin R, Gelven P. Transitional cell carcinoma of the endometrium. Gynecol Oncol 1996; 60:325-30.
22. Chen K. Extraovarian transitional cell carcinoma of female genital tract. Am J Clin Pathol 1990; 94:670-1.
23. Bass P, Birch B, Theaker J, Wells M. Low grade transitional cell carcinoma of the vagina: an unusual cause of vaginal bleeding. Histopathology 1994; 24:581-3.
24. Fettisof F, Haillot O, Lanson Y, Arbeille B, Lansac J. Papillary tumour of the vagina resembling transitional cell carcinoma. Pathol Res Pract 1990; 186:358-64.
25. Chen K. Brenner tumor of the vagina. Diagn Gynecol Obstet 1981; 3:255-8.
26. Wagner I, Bettendorf U. Extraovarian Brenner tumor: case report and review. Arch Gynecol 1980; 229:191-6.
27. Kariminejad M, Scully R. Female adnexal tumor of probable wolffian origin: a distinctive pathologic entity. Cancer 1973; 31:671-7.
28. Pschera H, Wikstrom B. Extraovarian Brenner tumor coexisting with serous cystadenoma. Gynecol Obstet Invest 1991; 31:185-7.
29. Egan A, Russell P. Transitional (urothelial) cell metaplasia of the fallopian tube mucosa: morphological assessment of three cases. Int J Gynecol Pathol 1996; 15:72-6.
30. Harnden P, Allam A, Joyce A, Patel A, Selby P, Southgate J. Cytokeratin 20 expression by non-invasive transitional cell carcinomas: potential for distinguishing recurrent from non-recurrent disease. Histopathology 1995; 27:169-74.
31. Miettinen M. Keratin 20: immunohistochemical marker for gastrointestinal, urothelial, and Merkel cell carcinomas. Mod Pathol 1995; 8:384-8.
32. Wang N, Zee S, Zarbo R, Bacchi C, Gown A. Coordinate expression of cytokeratins 7 and 20 defines unique subsets of carcinomas. Appl Immunohistochem 1995; 3:99-107.
33. Nagy G, Friedell G. Urinary bladder. In: Henson and Albores-Saavedra. Pathology of incipient neoplasia. edition. Philadelphia: WB Saunders, 1993:337-61.
34. Scully R, Richardson G, Barlow J. The development of malignancy in endometriosis. Clin Obstet Gynaecol 1966; 9:384-411.
35. Eifel P, Hendrickson M, Ross J, et al. Simultaneous presentation of carcinoma involving the ovary and uterine corpus. Cancer 1982; 50:163-70.
36. Ulbright TM, Roth LM. Metastatic and independent cancers of the endometrium and ovary: a clinicopathologic study of 34 cases. Hum Pathol 1985; 16:28-34.
37. Mostofi F, Sobin L, Torloni H. Histological typing of urinary bladder tumours. International Classification of Tumours. No. 10: 1973.
38. Mikuta JJ. International federation of gynecology and obstetrics staging of endometrial cancer 1988. Cancer 1993; 71:1460-3.
39. Zaino RJ, Kurman RJ, Diana KL, Morrow CP. Pathologic models to predict outcome for women with endometrial adenocarcinoma: the importance of the distinction between surgical stage and clinical stage - a gynecologic oncology group study. Cancer 1996; 77:1115-21.
40. Kelsey J, Hildreth N. Breast and gynecologic cancer epidemiology, edition. Boca Raton, Florida: CRC Press, 1983.
41. Silverberg S, Sasano N, Yajima A. Endometrial carcinoma in Miyagi Prefecture, Japan: histopathologic analysis of cancer registry-based series and comparison with cases in American women. Cancer 1982; 49:1504-10.
42. Soslow R, Rouse R, Hendrickson M, Silva E, Longacre T. Transitional cell neoplasms of the ovary and urinary bladder: a comparative immunohistochemical analysis. Int J Gynecol Pathol 1996; 15:257-65.
43. Wauters C, Smedts F, Gerrits L, Bosman F, Ramaekers F. Keratins 7 and 20 as diagnostic markers of carcinomas metastatic to the ovary. Hum Pathol 1995; 26:852-5.
44. Moll R, Lowe A, Laufer J, Franke W. Cytokeratin 20 in human carcinomas: a new histodiagnostic marker detected by monoclonal antibodies. Am J Pathol 1992; 140:427-47.
45. Berezowski K, Stastny J, Kornstein M. Cytokeratins 7 and 20 and carcinoembryonic antigen in ovarian and colonic carcinoma. Mod Pathol 1996; 9:426-9.
46. Loy T, Calaluce R, Keeney G, Myers J. Cytokeratin immunostaining in separating primary ovarian carcinoma from metastatic colonic adenocarcinoma. Mod Pathol 1996; 9:94A.
47. Ronnett B, Shmookler B, Kurman R. Immunohistochemical analysis of synchronous appendiceal and ovarian mucinous tumors in pseudomyxoma peritonei (PMP). Mod Pathol 1996; 9:97A.
48. Kroft S, Oyasu R. Urinary bladder cancer: mechanisms of development and progression. Lab Invest 1994; 71:158-74.
49. Robboy S. A hypothetic mechanism of diethylstilbestrol (DES)-induced anomalies in exposed progeny. Hum Pathol 1983; 14:831-3.